1. |
Bäckesjö CM, Li Y, Lindgren U, et al. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Miner Res, 2006, 21(7):993-1002.
|
2. |
Zhang JC, Zheng GF, Wu L, et al. Bone marrow mesenchymal stem cells overexpressing human basic fibroblast growth factor increase vasculogenesis in ischemic rats. Braz J Med Biol Res, 2014, 47(10):886-894.
|
3. |
Gutiérrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J, et al. Effects of intravenous administration of allogenic bone marrow and adipose tissue derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther, 2013, 4(1):11.
|
4. |
Hayashi H, Kume T. Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration. Biochemo Biophys Res Commun, 2008, 367(3):584-589.
|
5. |
De Val S, Chi NC, Meadows SM, et al. Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors. Cell, 2008, 135(6):1053-1064.
|
6. |
Kim SH, Cho K, Choi HS, et al. The forkhead transcription factor Foxc2 stimulates osteoblast differentiation. Biochem Biophys Res Commun, 2009, 386(3):532-536.
|
7. |
Wong RW, Rabie AB. Statin-induced osteogenesis uses in orthodontics:a scientific review. World J Orthod, 2006, 7(1):35-40.
|
8. |
Johnson ML, Kamel MA. The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol, 2007, 19(4):376-382.
|
9. |
尤武林, 王坤正, 段大鹏, 等. 插头/翼状螺旋转录因子C2基因慢病毒载体构建及其在BMSCs中的表达. 中国修复重建外科杂志, 2013, 27(5):535-540.
|
10. |
Phinney DG. Biochemical heterogeneity of mesenchymal stem cell populations:clues to their therapeutic efficacy. Cell Cycle, 2007, 6(23):2884-2889.
|
11. |
You WL, Fan LH, Duan DP, et al. Foxc2 over-expression in bone marrow mesenchymal stem cells stimulates osteogenic differentiation and inhibits adipogenic differentiation. Mol Cell Biochem, 2014, 386(1-2):125-134.
|
12. |
Cederberg A, Gronning LM, Ahren B, et al. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell, 2001, 106(5):563-573.
|
13. |
Nishimura R, Yoneda T. Role of Wnt in bone formation. Clin Calcium, 2006, 16(5):817-822.
|
14. |
Zeiter S, Lezuo P, Ito K. Effect of TGF beta1, BMP-2 and hydraulic pressure on chondrogenic differentiation of bovine bone marrow mesenchymal stromal cells. Biorheology, 2009, 46(1):45-55.
|
15. |
Eivers E, Demagny H, De Robertis EM. Integration of BMP and Wnt signaling via vertebrate Smad1/5/8 and Drosophila Mad. Cytokine Growth Factor Rev, 2009, 20(5-6):357-365.
|
16. |
Cho SW, Yang JY, Sun HJ, et al. Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells. Bone, 2009, 44(6):1069-1077.
|
17. |
Ashihara E, Takada T, Maekawa T. Targeting the canonical Wnt/β-catenin pathway in hematological malignancies. Cancer Sci, 2015, 106(6):665-671.
|
18. |
Isaeva AV, Zima AP, Shabalova IP, et al. β-Catenin:structure, function and role in malignant transformation of epithelial cells. Vestn Ross Akad Med Nauk, 2015, (4):475-483.
|